NewAmsterdam Pharma Company NV (NAMS) EUR0.12
Sell:$22.99Buy:$25.55
$0.49
(1.98%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Create an alert
Stocks and Shares ISASell:$22.99
Buy:$25.55
Change:$0.49
(1.98%)
$0.49
(1.98%)Prices delayed by at least 15 minutes
Sell:$22.99
Buy:$25.55
Change:$0.49
(1.98%)
$0.49
(1.98%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 22 August 2025 | Johannes Jacob Pieter KasteleinPresident | Sell Regular sell transaction (market) | 42,342 | $25.08 | $1,061,937.36 | 76,960 |
| 22 August 2025 | Johannes Jacob Pieter KasteleinPresident | Sell Regular sell transaction (market) | 7,658 | $25.49 | $195,202.42 | 69,302 |
| 21 August 2025 | Johannes Jacob Pieter KasteleinPresident | Sell Regular sell transaction (market) | 50,000 | $24.29 | $1,214,500.00 | 119,302 |
| 11 August 2025 | FRAZIER LIFESCIENCES SPONSOR LLCVenture Capital | Buy Regular purchase transaction | 471 | $23.98 | $11,293.97 | 3,026,604 |
| 16 July 2025 | Douglas F KlingCOO | Sell Option/Award related | 51,043 | $21.10 | $1,077,007.30 | 44,000 |
| 15 July 2025 | Douglas F KlingCOO | Sell Option/Award related | 44,025 | $21.38 | $941,254.50 | 47,544 |
| 15 July 2025 | Douglas F KlingCOO | Sell Option/Award related | 3,544 | $22.12 | $78,393.28 | 44,000 |
| 25 June 2025 | FRAZIER LIFESCIENCES SPONSOR LLCVenture Capital | Buy Regular purchase transaction | 1,260 | $18.26 | $23,011.63 | 3,026,133 |
| 24 June 2025 | FRAZIER LIFESCIENCES SPONSOR LLCVenture Capital | Buy Regular purchase transaction | 2,520 | $18.43 | $46,454.44 | 3,024,873 |
| 16 June 2025 | FRAZIER LIFESCIENCES SPONSOR LLCVenture Capital | Buy Regular purchase transaction | 8,584 | $19.50 | $167,381.13 | 3,022,153 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 13 December 2024 | BAIN CAPITAL LIFE SCIENCES INVESTORS LLCInvestment Company | Buy Regular purchase transaction | 1,632,653 | $24.50 | $39,999,835.23 | 1,632,653 |
| 10 December 2024 | FORGROWTH NAP BVVenture Capital | Sell Regular sell transaction (market) | 259,739 | $25.22 | $6,550,202.00 | 11,519,021 |
| 12 December 2024 | FORGROWTH NAP BVVenture Capital | Sell Regular sell transaction (market) | 140,048 | $25.25 | $3,536,212.00 | 11,176,424 |
| 11 December 2024 | FORGROWTH NAP BVVenture Capital | Sell Regular sell transaction (market) | 130,561 | $25.26 | $3,298,453.94 | 11,339,949 |
| 4 March 2025 | Louise Frederika KooijChief Accounting Officer | Sell Option/Award related | 150,000 | $20.37 | $3,055,500.00 | 15,000 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.